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To ensure a successful dental implant therapy, the presence of adequate vertical and horizontal alveolar bone is fundamental.
However, an insufficient amount of alveolar ridge in both dimensions is often encountered in dental practice due to the
consequences of oral diseases and tooth loss. Although postextraction socket preservation has been adopted to lessen the need for
such invasive approaches, it utilizes bone grafting materials, which have limitations that could negatively affect the quality of bone
formation. To overcome the drawbacks of routinely employed grafting materials, bone graft substitutes such as 3D scaffolds have
been recently investigated in the dental field. In this review, we highlight different biomaterials suitable for 3D scaffold fabrication,
with a focus on “3D-printed” ones as bone graft substitutes that might be convenient for various applications related to implant
therapy. We also briefly discuss their possible adoption for periodontal regeneration.
1. Introduction
Placement of endosseous implants has revolutionized mod-
ern dentistry, with a constantly increasing number of patients
seeking replacement of lost teeth with this modality of
treatment.
Since the overall success of dental implant therapy
depends on the presence of adequate bone volume at implant
sites [1], sufficient vertical and horizontal amounts of alveolar
ridge prior to dental implant placement are essential espe-
cially in the anterior maxilla, which is a highly demanding
aesthetic region.
Bone augmentation can be carried out using different
techniques: bone blocks or guided bone regeneration (GBR)
is mainly applied for horizontal grafting [2]. Vertical bone
augmentation employs more challenging and technique-
sensitive methods (vertical GBR, onlay grafting, inlay graft-
ing, and distraction osteogenesis [3, 4]) and is frequently
associated with high complication rates such as soft tissue
dehiscence and subsequent exposure of bone grafts to the oral
cavity [5].
In an attempt to overcome the obstacles related to
vertical bone augmentation, short dental implants have been
suggested as an alternative in the atrophic areas [6]. Despite
being an acceptable option in the posterior areas of both jaws,
bone grafting is still obligatory in anterior regions with severe
bone resorption to achieve final satisfactory aesthetic results.
Bone grafts serve as filling materials with alternating
properties of space maintenance, blood clot stabilization,
and scaffolding [7], by providing a temporary template to
support migration of cells from the periphery of the grafted
area [8]. Bone grafting materials are divided into autografts,
allografts, xenografts, and alloplasts, each with its own set of
advantages and disadvantages [9]. As a result, researchers are
constantly working on exploring new bone graft substitutes
with more predictable regenerative outcomes and minimal
complications. To this end, tissue engineering has become
more commonly used for oral bone grafting procedures.
The specific field of tissue engineering thatmainly focuses
on enhancing bone regeneration and repair by creating
substitutes to traditional bone grafting materials is referred
to as bone tissue engineering (BTE) [10] which started about
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three decades ago and has been witnessing a tremendous
growth ever since [11]. This could be ascribed to the high
regenerative potential of bone in comparison to other tissues
in the body, thus serving as a paradigm for general principles
in tissue engineering [12]. A classic BTE paradigm includes
the following three key components: biomaterials to provide a
scaffold for new tissue growth, cells, and signaling molecules
[11, 13].
Within this model, scaffolds can be either acellular or
cellular upon implantation. In the former, the overall archi-
tecture and geometry promote the recruitment of local stem
cell and or/osteoprogenitor cells [14], which could be possible
with “smart” cues and attachment motifs within the scaffold
architecture. On the other hand, the latter strategy involves
implantation of a scaffold combined with stem cell and
or/osteoprogenitor cells [14], which can be incorporated by
two methods: (i) cell seeding into a “prefabricated” scaffold,
a commonly applied tissue engineering strategy, and (ii) cell
encapsulation during scaffold fabrication made of hydrogel
polymer matrix [15], based on the immobilisation of cells
within a semipermeable membrane. This technique protects
cells from the immune system [16] and permits uniform cell
distribution within the construct [17].
In this narrative review, based on orthopaedic and den-
tal studies available on PubMed, MEDLINE, and Google
Scholar, we focus on the first key component of the tissue
engineering paradigm for applications in alveolar bone and
periodontal tissue regeneration, since scaffolds are consid-
ered the key players in successful tissue formation [14].
Biomolecules and cellular elements of the paradigm for this
specific application are discussed elsewhere [18].
2. Properties of 3D Scaffolds for
Applications in Alveolar Bone and
Periodontal Tissue Regeneration
Although conventional bone grafting materials serve the role
of a supporting matrix, they have several disadvantages: allo-
grafts, xenografts, and alloplasts are brittle, poorly process-
able into porous forms, and are unable to generate structures
tailored to the specific needs of patients. Likewise, they are
unable tomaintain the desired generated tissue volume under
mechanical forces, hindering their ability to provide a proper
template for effective cell interaction [8]. Although autografts
may have the ability to withstand mechanical forces, they are
difficult to shape and conform to a bony defect [19], which is
of a significant concern in the craniofacial region.
BTE has opened new doors for regeneration through the
introduction of scaffolds which possess three-dimensional
(3D) architecture that closely mimics native extracellular
matrix (ECM). Such arrangements eventually enhance cell
adhesion, proliferation, differentiation, and overall tissue
regeneration [20]. As a matter of fact, scaffold properties
are influenced by the used biomaterials and must be specific
for the application while in harmony with the native envi-
ronment to ensure that the defect area is replaced with a
healthy, functional tissue matching the original one, without
reparative scar formation [21].
In general, scaffolds must exhibit an adequate degree
of hydrophilicity [22, 23], roughness [24], and specific sur-
face topography; a topographic landscape on micro- and
submicrometer scales must be developed to replicate the
natural process of bone regeneration [25]. Nanotopography
increases the overall surface area, surface-to-volume ratio,
and surface roughness [26], which enhance the adhesion
between osteoblasts and the underlying scaffold surfaces [27].
As for microscale features, they facilitate cell penetration,
vascularization, and diffusion of nutrients [28] and offer
better spatial organization for cell growth and ECM pro-
duction [29]. Development of a multiscale scaffold has been
emphasized in periodontal tissue regeneration [30].
Other important design characteristics are overall poros-
ity, pore size, and interconnectivity. As human cancellous
bone demonstrates a total porosity between 30% and 90%,
any construct enclosing voids within this range is considered
suitable for bone regeneration [31]. However, extremely high
porosity can jeopardize the overall mechanical stability of a
scaffold by reducing its overall compressive strength [32]. For
alveolar bone regeneration applications, an overall porosity
of 70% has been applied in preclinical and clinical studies
[33–35]. Regarding pore diameter, a range between 150𝜇m
and 500 𝜇m facilitates vascularization and penetration of new
tissues [36] without compromising the mechanical strength
of the scaffold [11] or cell infiltration into inner surface
areas [37]. These consequential events are also dictated by
the presence of an interconnected pore network, which is
essential for cell growth into the interior of the scaffold to
prevent core necrosis [38].
To achieve success in bone regeneration, the template
should demonstrate mechanical strength close to native
tissues to support target cells, the surrounding tissues, and
newly formed ones, mainly in load-bearing areas, until full
tissue formation is achieved [39, 40]. In order to maintain
this process, degradation rate of a scaffold should be in
concordance with the remodeling processes of the target
tissue [41]. For dentoalveolar reconstruction, degradation
within 5-6 months is considered appropriate [42].
In addition, as implanted scaffolds should be biocompat-
ible and bioactive, the utilized biomaterials should not elicit
any inflammatory or cytotoxic reactions [43] and must evoke
a specific biological response at the interface of the material,
which results in the formation of a bond with the tissues [44].
Although the previously presented features constitute the
basics in scaffold designing for bone regeneration, it must
be noted that the design and balance between biomaterials
and scaffolds are a complex and interdisciplinary matter.
Furthermore, this aspect can become more complicated
when alveolar bone regeneration is attempted along with
cementum and periodontal ligament tissues. In this scenario,
spatial organization is necessary by utilizing a multiphasic
scaffold, which encloses variable architectural and chemical
composition to closely capture the structural organization of
native tissue and/or its cellular and biochemical composi-
tion [45]. Therefore, “compartmentalization” is essential for
controlling the spatiotemporal events resulting in effective
regeneration of the periodontal complex [45] which could
prevent tooth ankylosis. This can be achieved by ensuring
International Journal of Dentistry 3
Figure 1: Multiphasic scaffold aimed at multiple tissue regeneration (periodontal ligament, cementum, and alveolar bone). Courtesy of Park
et al., 2012 [46].
compartmentalized formation of bone and functionally ori-
ented periodontal ligament fibers (PDL) that are integrated
over time [45]. Figure 1 illustrates a multiphasic scaffold
with channel-like “fiber-guiding architecture” of the PDL
compartment displaying a thickness of 0.250mm to mimic
the width of an adult periodontal ligament space [46].
3. Applied Biomaterials Used in the
Fabrication of 3D Scaffolds for Alveolar
Bone Regeneration
As biomaterials strongly influence the overall properties of
a scaffold, it is important to comprehend their individual
characteristics to allow for appropriate selection in specific
applications taking into consideration the notion that bio-
materials differ in their cellular affinity [47], which influ-
ences adhesion, proliferation, and the overall regeneration
outcome. As cell adhesion is mediated via integrins, such
differences between biomaterials can be further explored.
Below, we present biomaterials that can be mainly applied
in alveolar bone regeneration and are compatible with new
scaffold fabrication techniques.
3.1. Biodegradable Natural Polymers. Natural polymers,
which include proteins and polysaccharides, are the
first biomaterials to be recruited in different clinical
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applications because of their high biocompatibility, good
cell recognition, enhanced cellular interactions in the
surrounding environment [48], and hydrophilicity [49]. Due
to these properties, they have been thoroughly investigated
as hydrogels in the earliest work of cell encapsulation in
tissue engineering, demonstrating successful results [50–54].
Collagen is one of the most widely expressed proteins in
the humanbody, providing strength and structural stability to
many tissues from skin to bone [55]. Being the major organic
component of the ECM in native bone makes collagen an
attractive biomaterial for BTE applications [56]. It is well
documented that collagen matrices promote cell adhesion,
proliferation, and osteogenic differentiation of bone marrow
stromal cells, in vitro [55]. Similarly, the denatured form of
collagen termed gelatin [57] enhances osteoblast adhesion,
migration, andmineralization as it contains several biological
and functional groups that promote such activities [58].
Regarding polysaccharides, chitosan is a popular biomate-
rial in bone tissue engineering due to its appealing character-
istics; it displays antibacterial and antifungal activities, rapid
blood clot formation, and analgesic properties [59], all of
which render chitosan useful in wound healing acceleration
that would minimize the risk of scaffold contamination and
postoperative infections, thus preventing eventual exposure
and failure of the scaffold.
For the same applications, alginate is another commonly
investigated polysaccharide. It is highly processable into
different scaffold types, which encourages its employment
in BTE and regenerative medicine [60], and has been the
most studied biomaterial for encapsulation of living cells
[16]. Interestingly, alginate and chitosan do not exist within
the human body, but they display structural similarities to
glycosaminoglycans (GAGs) found in the ECM of human
tissues such as bone [61], making them attractive candidates
for applications in tissue regeneration.
Despite their good biological properties, the previously
mentioned natural polymers lack bioactivity [62], which is
the key factor in promoting hard tissue formation. They also
share weak mechanical characteristics and somewhat rapid
degradation rate [60, 63, 64] through enzymatic reaction [65].
To overcome such undesired properties, scaffolds based
on natural polymers are usually combined with bioactive
materials (e.g., bioceramics) or mechanically strong ones
(e.g., synthetic polymers or metals), depending on the area of
application (e.g., load-bearing or not). Interestingly, although
bioceramics are mechanically weak as well, they tend to
increase the overall compressive strength of natural polymer
based scaffolds [66].
3.2. Biodegradable Synthetic Polymers. Biodegradable syn-
thetic polymers have generated interest in BTE because of
their relatively low cost and ability to be produced in large
quantities with long shelf life in comparison to their natural
counterparts [37]. The most investigated biomaterials of this
group are aliphatic polyesterswhich include polycaprolactone
(PCL), polylactic acid (PLA), polyglycolic acid (PGA), and
their copolymer poly(lactic-co-glycolic) acid (PLGA).
Polycaprolactone (PCL) is the most popular aliphatic
polyester in medical applications; it has been used in medical
devices for the last 30 years [35] and has been investigated
in craniofacial repair [67]. PCL is an excellent candidate for
BTE applications due to its biocompatibility [68], suitability
for various scaffold fabrication techniques [69], remarkably
slow degradation rate, and mechanical stability [40]. It is
suggested that the latter two traits might allow for a better
maintenance of generated bone volume and its contour over
time. However, PCL is hydrophobic in nature [70] which is
also responsible for the inferior cell affinity and poor cellular
responses and interactions to the surface [71]. Similar to
PCL, polylactic acid (PLA) and poly(lactic-co-glycolic acid)
(PLGA) are hydrophobic while polyglycolic acid (PGA) is
hydrophilic, keeping in mind that these polymers still have
higher rates of degradation in comparison to PCL [72]. But,
in general, aliphatic polyesters display a slow degradation
rate in correlation to natural polymers and bioceramics
[73]. Synthetic polymers degrade by hydrolysis [65] which
can be in the form of bulk degradation or surface erosion
[74, 75]. Most of the available polyesters degrade by the
former mechanism [76] characterized by hydrolysis within
the interior part of the biomaterial, resulting in an empty shell
formation, while the size is maintained for a considerable
amount of time [77]. This feature is considered appealing
for scaffold utilization as a bone graft substitute and less
suitable for drug-delivery purposes. Still, aliphatic polyesters
release acidic byproducts upon degradation, which can result
in tissue necrosis and subsequent scaffold failure with chronic
exposure [11]. Therefore, they are usually combined with
bioceramics that enhance the bioactivity of a construct and
tend to neutralize the acidic byproducts by elevating the
overall pHvalue for the scaffold [78] tomaintain tissue health.
Counteracting acidic byproducts and overall pH buffering
can also be achieved when polyesters are combined with
metals [79]. Despite the acidic byproducts and the lack of
bioactivity, aliphatic polyesters are moldable for fabrication
into the required shapes and have good mechanical proper-
ties [80, 81].
3.3. Bioceramics. Bioceramics are inorganic biomaterials
constituting different categories, among which are calcium
phosphate bioceramics and bioactive glass with very well-
documented applications as bone fillers in the dental field
[82]. Calcium phosphate bioceramics enclose hydroxyapatite
(HAp), tricalciumphosphate (𝛼-TCP and𝛽-TCP), and bipha-
sic calcium phosphate (BCP), all of which can also be in the
formof injectable cementmaterials (pastes) that aremoldable
and easy to handle and harden when left in situ. Moldable
calcium phosphate materials allow for intimate adaptation
to complex defects, which is difficult to accomplish with
conventional bone grafting materials [83].
Bioceramics are attracting more attention in bone recon-
struction due to their unlimited availability, bioactivity, excel-
lent biocompatibility, hydrophilicity, similarity to native bone
inorganic components, osteoconductivity [29], and reported
potential osteoinductivity [84], which is the ability to induce
ectopic bone formation by instructing the surrounding in
vivo environment to do so [85]. This potential activity can
be attributed either to the surface of bioceramics which
absorbs and exhibits osteoinductive factors or to the gradual
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release of calcium and phosphate ions into the surrounding
environment, subsequently stimulating the differentiation of
osteoprogenitor cells into osteoblasts. Still, both theories are
yet to be confirmed [86]. The importance of incorporating
calcium phosphates in 3D scaffolds for alveolar bone regen-
eration has already been demonstrated in the literature [34].
Themost investigated calcium phosphate ceramic in BTE
is hydroxyapatite (HAp) because it shares the same chemical
composition of native bone minerals, which positively influ-
ences adhesion and proliferation of osteoblasts [87]. Despite
this important feature, HAp takes a long time to degrade
when in the “crystalline form” in vivo, causing the remaining
particles to impede complete bone formation and increase
the risk for infection and exposure in oral and maxillofacial
regions [88]. Consequently, applications of crystalline HAp
are being eventually substituted by amorphous hydroxyap-
atite, which has a faster degradation rate [89].Modification of
HApdegradation rate can also be achieved by its combination
with other biomaterials of faster kinetics, such as natural
polymers [90].
The second most widely studied calcium phosphate
ceramic is 𝛽-tricalcium phosphate (𝛽-TCP), because of its
ability to form a strong bone-calcium phosphate bond
[84] and its faster degradation rate [9]. Interestingly, when
tricalcium phosphate is combined with HAp, a mixture
termed biphasic calcium phosphate (BCP) is produced [91].
In comparison to other calcium phosphate ceramics, BCP
has significant advantages in terms of controlled bioactivity,
stability, while promoting bone ingrowth especially in large
bone defects [92], and controllable degradation rate [93] as
BCP has a higher degradation rate than HAp, yet slower than
that of 𝛽-TCP [94].
Another biomaterial that belongs to bioceramics and is
investigated in BTE is bioactive glass (BG), which is a silicon
oxide with substituted calcium [18]. When exposed to body
fluids, a layer of calcium phosphate forms on the surface of
bioactive glass, which chemically binds to bone [95]. The
specific type of bioglass used as a synthetic graft in intraoral
applications (termed 45S5 Bioglass) [18] has a very slow
degradation rate because it converts to a HAp-like material
in the physiologic environment [96, 97]. Typically, bioce-
ramics degrade via multiple mechanisms: physiochemical
dissolution accompanied by possible phase transformation,
multinucleated cell-mediated degradation, and mechanical
fragmentation due to loss of structural integrity by the two
former mechanisms [76].
Although bioceramics have inviting qualities, they are
extremely brittle and difficult to shape into the desired
structures because of their stiffness and low flexibility and
moldability [98]. They have weak mechanical strength [99]
and fracture toughness [100], which limit their applica-
tions to non-load-bearing areas. However, their combination
with mechanically strong biomaterials, such as synthetic
polyesters or metals, tends to eliminate brittleness, difficulty
in shaping, and weak mechanical strength [101, 102].
3.4. Metals. Metallic biomaterials are extensively applied
in dental and orthopaedic fields to support the replace-
ment of lost bone structures because of their excellent
mechanical properties [103, 104]; they display high strength,
toughness, and hardness, in comparison to polymers and
ceramics, making them suitable for applications in load-
bearing areas [105]. It is reported that metals enhance the
mechanical properties of a scaffold by decreasing the pore size
[106].
Within this group of biomaterials, titanium and tita-
nium alloys are encouraged in bone regeneration due to
their high biocompatibility, appropriate mechanical prop-
erties, and elasticity [107]. Different studies reported that
titanium-based 3D scaffolds display good hydrophilicity,
which enhances mineral deposition and encourages cell
attachment and proliferation in vitro [107] and new bone
formation without any signs of inflammation or necrosis in
vivo [108].
Nonetheless, lack of biodegradability of titanium and
titanium alloys is a major disadvantage andmight discourage
their applications in bone regeneration due to the need of a
second surgery for removal, which can compromise patient
satisfaction and increase health care costs [103].
In the past decade, magnesium and magnesium alloys
have been thoroughly researched and found to be extremely
appealing materials for orthopaedic applications [103] with
great potential in BTE; they have mechanical properties close
to native bone and are completely biodegradable [103] which
eliminates the need for a second surgery to retrieve the scaf-
fold. Although magnesium and magnesium alloys degrade
by corrosion [109], their byproducts are biocompatible and
do not elicit adverse reactions that could negatively affect
surrounding tissues [110].
Magnesium and its alloys are osteoconductive, play a
role in cell attachment [103], and tend to increase the
expression of osteogenicmarkers in vitro [111]. Although pure
magnesium has a rapid rate of degradation in vivo [112], this
can be controlled through the utilization ofmagnesium alloys
[113] or by coating pure magnesium with titanium [114] or
ceramics [115]. Similar to natural and synthetic polymers,
metals lack bioactivity.
In regard to all the previously described biomaterials,
each has remarkable characteristics and individual limita-
tions. Henceforth, it is very common to combine two or
more different biomaterials to produce a “synergistic effect”
in the overall resulting properties [116] and improve the
mechanical, biological, and degradation kinetics of a scaffold
[117]. Additionally, bone tissue is made of organic and
inorganic components [118], thereby making it more difficult
for one biomaterial to simulate the complex bone tissue envi-
ronment and possess the required characteristics of the target
tissue [21]. These scaffolds are referred to as “composite” or
“hybrid” and whenever three biomaterials are incorporated
the term “ternary” can be used. Composite scaffolds used
for BTE applications are divided into “polymer/ceramic,”
“ceramic/metal,” and “polymer/metal.”The former type is the
most popular among composites and has been thoroughly
studied by researchers in the orthopaedic field for the last
five years [119]. However, the literature confirms that various
composite scaffolds support attachment, proliferation, and
differentiation of osteoblasts while maintaining the final
shape of newly formed bone [119].
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Composites, whether ternary or not, consist of a major
component (matrix) and minor components (filler); the
material which constitutes more than 50% of the blend is
considered the major element, while the material/materials
that are less than 50% represent the minor component [120].
4. Advances in 3D Scaffold
Fabrication Techniques
Different techniques are employed in the fabrication of 3D
scaffolds, with the conventional methods including particle
leaching, gas foaming, freeze drying, phase separation, fiber
meshes/fiber bonding, melt molding, and solution casting
[14]. However, heterogeneities in pore size, porosity, inter-
connectivity, and architecture are unavoidable with these
techniques, which can complicate drawing conclusions from
experiments that assess the effect of scaffold properties on
newly formed tissues [121]. Moreover, these techniquesmight
not be applicable for the fabrication of a custom-made
scaffold with finely tuned architecture that replicates the
complexity of native tissues and precisely conforms to the
shape of a certain defect.
With the development of solid-freeform fabrication (SFF)
techniques, also known as rapid prototyping (RP), it became
possible to create scaffolds with precise external shape,
internal morphology, and “reproducible” three-dimensional
architecture, despite their complexity [122].
These technologies represent additive manufacturing as
they build complex structures layer by layer by “3D printing,”
with one of the following techniques: inkjet printing, laser-
assisted printing (e.g., Selective Laser Sintering (SLS) and
Stereolithography (SLA)), and extrusion printing (e.g., fused
deposition modeling (FDM)) [123]. Each printing method
is compatible with specific biomaterials and differs in reso-
lution. For example, laser-assisted methods enable printing
of diverse biomaterials with wide range viscosities [124].
Such diversity overcomes the limitations of inkjet printing
in which low-viscosity inks are needed to prevent clogging
of the nozzle of the printing machine that would eventually
compromise printing quality, while extrusion printing is
restricted to thermoplastic biomaterials such as PCL [123,
125]. In regard to bioprinting, inkjet, laser-assisted, and
extrusion-based techniques are utilized in printing of living
cells and constructs [123]. As a consequence, these technolo-
gies can be further explored in cell encapsulation and cell-
based therapies, especially that they allow for controlled posi-
tioning of cells with precision, which could mimic the tissue
interface and the surrounding microenvironment. However,
these applications are generally reserved to hydrogel scaffolds
[126], made of natural or synthetic polymers [125]. Different
3D printing methods are demonstrated in Figure 2 [123].
These new techniques utilize computer-aided design
(CAD) and computer-assisted manufacturing (CAM) tech-
nologies to 3D-print a desired structure based on a CAD
file that has already defined the exact dimensions of a
scaffold [126]. This approach can be applicable in fabricating
constructs that conform to a specific anatomical shape; in
a typical clinical case scenario, CAD models are produced
based on images from computed tomography (CT) scans of
a patient-specific bone defect to develop a “custom-made”
bone graft substitute which could be helpful in regenerating
defects with complex geometry [127] as illustrated in Figure 3
[128]. Image-based 3D-printed scaffold following this scheme
displayed promising results in preclinical investigations in
periodontal regeneration with the need of further assessment
for future employment in clinical practice [46, 128]. In the
literature, few studies have focused on the concept of custom-
made scaffolds for alveolar bone regeneration, by using
subtractive technology (milling of a commercially available
block, dictated byCAD/CAMtechnologies), whichmight not
be as sophisticated due to the lack of layer-by-layer addition
[129–131].
Although RP techniques are capable of producing con-
structs with satisfying mechanical strength by precisely con-
trolling the overall geometrical design and porosity, these
characteristics can still be limited by the machine’s resolu-
tion and material repertoire. Due to the lack of sufficient
resolution to fabricate nano- and submicrometer structures,
a combination of RP techniques with different fabrication
methods such as electrospinning [132] has been proposed to
allow for the construction of efficient biomimetic constructs.
5. Applications of 3D-Printed
and/or Compartmentalized Scaffolds
in Alveolar Bone and Periodontal
Tissue Regeneration
With the increased need for “optimal” tissue regeneration,
“3D-printed” scaffolds have been recently investigated in
different periodontal applications: guided bone regeneration
(GBR), guided tissue regeneration (GTR), vertical bone
augmentation, sinus augmentation, and socket preservation,
showing variable outcomes of success.
PCL has been the most utilized biomaterial in these
applications, probably because of its well-documented pos-
itive outcomes in hard tissue regeneration in the field of
orthopaedics [119].
Regarding periodontal tissue regeneration, a novel
anatomically shaped human-molar and rat-incisor 3D-
printed PCL/HAp scaffold showed promising results in
terms of inducing regeneration by “cell homing” instead
of cell delivery in a rat model [133]. In another rat model
[46, 128], the concept of “compartmentalization” was applied
to achieve regeneration of periodontal ligament, cementum,
and alveolar bone, by utilizing a custom-made 3D-printed
PCL scaffold which enclosed an alveolar bone interface
and a PDL interface with fiber-guiding architecture. The
biphasic construct allowed not only for the regeneration of
obliquely oriented periodontal fibers, cementum-like tissue,
and alveolar bone, but also for a greater control of tissue
infiltration when compared to random porous scaffolds.
Similarly, multiphasic periodontal tissue regeneration was
achieved with a 3D-printed PCL/HAp triphasic scaffold that
allowed for spatiotemporal delivery of multiple proteins, in
vivo [134].
Recently, a biphasic PCL scaffold utilizing two scaf-
fold fabrication techniques and cell sheet technology was
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Figure 2: Different 3D printing methods used to manufacture 3D scaffolds for various applications. Courtesy of Obregon et al., 2015 [123].
investigated in the regeneration of the alveolar bone and
periodontal tissues [33]. In fact, cell sheet technology was
tested as a part of the scaffold to provide biomechanical
support during wound healing process, which was lacking
in a material-free approach of cell sheet technology in
periodontal regeneration [135]. The scaffold enclosed two
compartments manufactured by two different techniques
and of different biomaterials: the bone compartment was
constructed from 𝛽-TCP/PCL by fused deposition modeling
(FDM) and then thermally incorporated with an electrospun
PCL membrane enclosing cell sheets, representing the PDL
compartment. After being tested in a subcutaneous ratmodel,
results demonstrated successful regeneration of cementum,
alveolar bone, and periodontal ligament. Early bone markers
confirmed that FDMbone interface promoted early bone for-
mation. However, there was no functional orientation of the
PDL fibers, as no specific cell oriented architecture was con-
tained in the design. To address this finding, the researchers
developed a second generation of the same scaffold [34]
but with specific modifications of the PDL compartment,
by including superimposed concentrically oriented rings in
the membrane, fabricated by melt electrospinning to allow
for some level of tissue organization. This interface was also
more porous to improve cell interactions and vascularization.
The bone compartment was modified to enhance alveolar
bone regeneration by coating the 𝛽-TCP/PCL construct with
calcium phosphate (CaP). By employing the same animal
model, results revealed higher bone formationwith improved
PDL fiber orientation and vessel ingrowth.
Despite the promising results in vivo, 3D-printed PCL-
based scaffolds showed less promising outcomes in clinical
studies.
A “prefabricated” 3D PCL scaffold printed by FDM was
tested for socket preservation in a randomized clinical trial
[35]. Although the scaffoldmaintained the ridge height better
after 6 months, this finding can be expected because no
filler was used in the control group. The efficacy of PCL-
based scaffolds as space fillers in socket preservation should
be interpreted with caution, because comparison with other
socket preservation techniques is still lacking. Most impor-
tantly, the scaffolds showed minimal signs of degradation
6 months following intervention and fibrous invasion was
reported in one patient due to manual shaping for friction
fit within the extraction socket. One might conclude that
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Figure 3: CADmodels are produced based on computed tomography (CT) scans of a patient-specific bone defect to develop a custom-made
bone graft substitute. Courtesy of Park et al., 2014 [128].
“custom-made” 3D-printed PCL scaffolds based on medical
imaging could show more favorable results by allowing
precise adaptation to the bony defect. However, adverse out-
comes were reported when a custom-made image-based 3D
fiber-guiding PCL/HAp scaffold printed by SLS was applied
in GTR in a recent case report, as shown in Figure 4 [136].
After thirteen months of scaffold implantation, soft tissue
dehiscence was reported with histological and molecular
weight analysis revealing that almost 76% of the scaffold
mass remained with minimal bone repair. This result can
be interpreted by the very slow degradation profile of PCL
in addition to its inferior cell affinity and weak osteocon-
ductive activity. The final outcome might have also been
compromised due to the low resolution of the applied 3D
printing technology. Interestingly, one might attribute the
end result to the acidic byproducts upon degradation, as
well. Nonetheless, this matter is debatable, as some data in
the literature have revealed that metabolic pathways easily
remove PCL byproducts and thus PCL does not produce a
local acidic environment as other aliphatic polyesters [137,
138].
The slow degradation of PCL has been considered appeal-
ing in hard tissue regeneration [40], but this might be valid
for orthopaedic applications only, because there are key
differences in the behaviour between long bones and alveolar
bone as remodeling is slower in the former in comparison
to the latter [139]. Although it is very well documented
that bioceramics tend to control the degradation rate of
polyesters [140], the percentage of HAp that was combined
with PCL in this case report (4%) might not have been
sufficient to accelerate the degradation profile. As a matter
of fact, accelerated degradation of PCL was achievable with
a much higher percentage of HAp in an in vitro investigation
[140].
Interestingly, this fiber-guiding scaffold model in GTR
was successful in preclinical studies on rats [46, 128]. The
discrepancy in results could be due to the differences between
rats and humans in terms of healing window, anatomic
structures, and host responses [141].
Another biomaterial that has been widely tested as part
of 3D scaffolds for periodontal applications is bioceramics,
mainly in sinus and bone augmentation procedures. In a
sheep animal model, a prefabricated 3D-printed scaffold,
made of biphasic ceramic (𝛼-TCP + HAp), was compared
to bovine bone (Bio-Oss) and particulate 𝛽-TCP for vertical
bone augmentation [142]. The scaffold eliminated the need
for membranes and provided better mechanical support to
the newly formed tissues, which can be explained by the
fact that when 𝛼-TCP comes into contact with body fluids,
it converts to HAp which has a very slow degradation rate.
Similarly, a 3D-printed BCP scaffold (HAp (30%), 𝛽-TCP
(60%), and 𝛼-TCP (10%)) showed favorable outcomes as a
bone graft substitute for sinus augmentation in vivo in terms
of abundant deposition of newly formed bone tissue within
the biomaterial pores, which could be promising in future
clinical applications [143].
Specific conclusions can be extrapolated from the previ-
ous studies about the use of certain biomaterials in scaffolding
for various periodontal applications. For example, the use
of PCL as the only biomaterial in a scaffold could be
discouraged mainly due to its slow degradation rate which
can lead to wound dehiscence and subsequent failure of
tissue regeneration, also due to its inferior cell affinity [71].
If combined with bioceramics, an increase in the weight
percentage of the bioceramic should be utilized to accelerate
the degradation profile. Likewise, increased porosity of the
bulk scaffold construct can assist with more rapid tissue
ingrowth that can further drive the degradation process.
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Figure 4: Custom-made 3D-printed PCL/HAp scaffold based on images from computed tomography (CT) scans and combined with
CAD/CAM technologies for periodontal tissue regeneration. Courtesy of Rasperini et al., 2015 [136].
Other aliphatic polyesters might be discouraged as well
due to their acidic byproducts unless counteracted by the
combination of bioceramics or metals. In a recent in vitro/in
vivo investigation, magnesium/PLGA scaffold was applied
in socket preservation, in which magnesium was able to
counteract the acidic degradation of PLGA, thus decreasing
the risk for tissue inflammation and eventually enhancing
osteogenesis [79]. Still, it should be kept inmind that the ideal
percentage of biomaterials to eliminate the risk of adverse
effects may be difficult to determine for clinical uses.
Regarding GTR, where contact with bacteria and expo-
sure are more likely to occur, natural polymers could be
the best choice for this specific application, such as chitosan
which has antibacterial properties that could decrease the
chance of bacterial contamination and subsequent exposure.
Gelatin can also be recommended in this application, and
it has already been investigated in vitro as the biomaterial
of a “periodontally inspired” scaffold, created by direc-
tional freeze-casting [144]. Despite having relatively low
compressive resistance, gelatin displayed attractive biological
properties because intrinsic cell interactions with the scaffold
surface are still possible in the presence of adhesive RGD
motifs, making cell affinity and growth more significant
[145]. To overcome the mechanical weakness of gelatin,
incorporation of this platform into the previously described
synthetic polymer-based, fiber-guiding 3D scaffold system
[46, 128] has been proposed.
It must be taken into consideration that natural polymers
must be combined with mechanically strong materials; in
GTR applications, the scaffold serves a dual role: a graft-
ing material and a membrane. Since space maintenance is
required for periodontal regeneration, it is essential to utilize
a mechanically strong scaffold.
For applications in alveolar bone regeneration, augmenta-
tion, and socket preservation, scaffolds made of bioceramics
can be recommended. Nevertheless, using bioceramics alone
can be questionable for clinical applications, because of their
weak mechanical properties. To overcome such limitations,
bioceramics can be combined with mechanically strong
biomaterials as mentioned earlier.
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In non-load-bearing areas, collagen could be the pre-
ferred biomaterial in such combination. Better outcomes are
to be expected with the incorporation of collagen because a
bioceramic/collagen mix is the closest replicate of the ECM
composition of native bone [146].
Specifically, the combination of collagen with hydroxya-
patite is encouraged in bone tissue regeneration [146] due to
the compositional similarities to native tissue and reasonable
degradation rates for clinical uses [90].
In bone tissue regeneration, care must be taken that
this process might take a long time in case of severe ridge
resorption, because bone regeneration through scaffolds
commences at the peripheries, where contact points between
the biomaterial and native bone exist. However, this can be
resolved with advances in tissue engineering and further
investigations, by creating different points of bone nucleation
through engineering with stem/osteoprogenitor cells [143].
To this end, studies on 3D-printed scaffolds in the
periodontal field have focused on biomaterials, new and/or
functional tissue formation, and spatial organization mainly
when multiple tissue regeneration was attempted. Accord-
ingly, other characteristics still need to be addressed more
thoroughly, such as vascularization, analysis of landscape
topography, and degradation profile and kinetics. Moreover,
“image-based” 3D-printed scaffolds must be investigated in
alveolar bone regeneration prior to placement of dental
implants, as there are no published studies on this specific use.
6. Recommendations and Future Directions
BTE is based not only on cellular and molecular events and
interactions, but also on the development of biomaterials and
scaffolds with prescribed biomechanical properties, repre-
senting a fundamental part of the BTE paradigm.
Dental literature on 3D scaffolds and related biomaterials
as alternative to bone grafts is still scarce, with extremely lim-
ited clinical trials. Validation of the efficacy of scaffolds tested
in animal models is obligatory, because the already published
results are not representative due to small defects, graft size,
and also a completely different healing process in small ani-
mals. Randomized controlled clinical trials are mandatory,
with adequate number of patients and long-term follow-up of
implant therapy following scaffold employment in preimplant
augmentation procedures. Thorough evaluation of biological
and mechanical properties, as well as degradation profiles
of 3D scaffolds in periodontal applications, is needed. The
effect of 3D scaffolds on “blood clot stabilization” should be
assessed, as it is an important prognostic factor in alveolar
bone regeneration [7]. Moreover, scaffolds should be tested
as part of a complete tissue regeneration protocol, in combi-
nation with new techniques of soft tissue management which
is the key for optimum regenerative outcomes [147]. Due
to the existing limitations of scaffold fabrication techniques,
investigations of technique combination must be evaluated
as an acceptable modality for producing scaffolds with clear-
cut scales on different levels. As scaffold stabilization rep-
resents an important factor in preventing micromotion and
compromised regeneration outcomes, different stabilization
techniques could be investigated as well (press-fit graft, fibrin
glue) since fixation with screws and pins might compromise
the scaffold integrity, especially in large defects.
7. Conclusions
Scaffolding matrices are an attractive alternative to bone
replacement grafts in surgical procedures related to endoss-
eous implant placement, that is, vertical and/or horizontal
bone augmentation, socket preservation, and sinus augmen-
tation. Scaffolding matrices can also be used as a membrane
and grafting material in periodontal tissue regeneration.
A scaffold should be biocompatible, biodegradable, and
bioactive and should be made of a hybrid of biomaterials,
as the combination of different biomaterials is superior to a
pure material, mechanically and biologically. Regardless, it is
still unknown which combination of materials is optimal for
alveolar bone regeneration.Muchwork lies ahead to translate
the promising results of preclinical studies into clinical reality.
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